로딩 중…
지수 로딩 중…
Hugel
145020· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩242,000-3.59%
2026-06-19
Price Chart
Hugel-34.95%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 2.98T KRW |
| Revenue | 451.93B KRW |
| Net Income | 152.42B KRW |
| Total Assets | 1.08T KRW |
| Net Assets | 980.16B KRW |
| Employees | 609 |
| Value | |
| P/E | 19.54x |
| P/B | 3.04x |
| PEG | 0.49x |
| P/S | 6.59x |
| EV/EBITDA | 41.42x |
| FCF Yield | 4.59% |
| Profitability | |
| ROE | 15.55% |
| ROA | 14.15% |
| Op. Margin | 46.36% |
| Revenue Growth | 29.86% |
| Earnings Growth | 39.73% |
| Financial Health | |
| Debt Ratio | 9.86% |
| Total Debt | 26.00B KRW |
| FCF | 136.66B KRW |
| Cash | 249.30B KRW |
| Current Ratio | 7.49x |
| Net Debt/EBITDA | -3.36x |
| Performance | |
| 1Y Return | -34.95% |
| 1M Return | -4.72% |
| From 52W High | -38.27% |
| 1Y MDD | -44.85% |
| Trading | |
| Volume | 64,251 shares |
| Foreign Own. | 58.04% |
| Per Share | |
| EPS | 12,242 KRW |
| BPS | 92,935 KRW |
Company Info
Established in 2001, this global medical aesthetics company listed on KOSDAQ in 2015 and absorbed Hugel Pharma in 2018. Its core business involves the research, development, manufacturing, and sales of Type A botulinum toxin and hyaluronic acid fillers, including products like BOTULAX, The Chaeum, and Wellage. The company drives innovation through technologies such as artificial intelligence and robotics, providing comprehensive solutions for diverse aesthetic needs to enhance corporate value. Hugel was established in 2001 and is headquartered in Chuncheon-si, Gangwon Special Self-Governing Province.